img

Global NGS-based RNA-sequencing Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global NGS-based RNA-sequencing Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.
Due to the COVID-19 pandemic, the global NGS-based RNA-sequencing market size was US$ 1832.5 million in 2022 and is forecast to a readjusted size of US$ 5746.2 million by 2034 with a CAGR of 17.4% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Sequencing by Synthesis accounting for % of the NGS-based RNA-sequencing global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Research & Academia segment is altered to an % CAGR throughout this forecast period.
The global key companies of NGS-based RNA-sequencing include Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific and Roche, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States NGS-based RNA-sequencing market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe NGS-based RNA-sequencing landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global NGS-based RNA-sequencing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global NGS-based RNA-sequencing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global NGS-based RNA-sequencing market. Readers of the report can become informed about current and future trends of the global NGS-based RNA-sequencing market and how they will impact market growth during the forecast period.



By Company


Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing

Segment by Application


Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of NGS-based RNA-sequencing in global and regional level.
Chapter 3Detailed analysis of NGS-based RNA-sequencing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NGS-based RNA-sequencing revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Sequencing by Synthesis
1.2.3 Ion Semiconductor Sequencing
1.2.4 Single-molecule Real-time Sequencing
1.2.5 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global NGS-based RNA-sequencing Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Research & Academia
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global NGS-based RNA-sequencing Market Size (2018-2034)
2.2 NGS-based RNA-sequencing Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global NGS-based RNA-sequencing Market Size by Region (2018-2024)
2.4 Global NGS-based RNA-sequencing Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 NGS-based RNA-sequencing Countries Ranking by Market Size
3 NGS-based RNA-sequencing Competitive by Company
3.1 Global NGS-based RNA-sequencing Revenue by Players
3.1.1 Global NGS-based RNA-sequencing Revenue by Players (2018-2024)
3.1.2 Global NGS-based RNA-sequencing Market Share by Players (2018-2024)
3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by NGS-based RNA-sequencing Revenue
3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2022
3.5 Global Key Players of NGS-based RNA-sequencing Head office and Area Served
3.6 Global Key Players of NGS-based RNA-sequencing, Product and Application
3.7 Global Key Players of NGS-based RNA-sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global NGS-based RNA-sequencing Breakdown Data by Type
4.1 Global NGS-based RNA-sequencing Historic Revenue by Type (2018-2024)
4.2 Global NGS-based RNA-sequencing Forecasted Revenue by Type (2024-2034)
5 Global NGS-based RNA-sequencing Breakdown Data by Application
5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2018-2024)
5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America NGS-based RNA-sequencing Revenue by Company (2021-2024)
6.2 North America NGS-based RNA-sequencing Revenue by Type (2018-2034)
6.3 North America NGS-based RNA-sequencing Revenue by Application (2018-2034)
6.4 North America NGS-based RNA-sequencing Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe NGS-based RNA-sequencing Revenue by Company (2021-2024)
7.2 Europe NGS-based RNA-sequencing Revenue by Type (2018-2034)
7.3 Europe NGS-based RNA-sequencing Revenue by Application (2018-2034)
7.4 Europe NGS-based RNA-sequencing Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific NGS-based RNA-sequencing Revenue by Company (2021-2024)
8.2 Asia Pacific NGS-based RNA-sequencing Revenue by Type (2018-2034)
8.3 Asia Pacific NGS-based RNA-sequencing Revenue by Application (2018-2034)
8.4 Asia Pacific NGS-based RNA-sequencing Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America NGS-based RNA-sequencing Revenue by Company (2021-2024)
9.2 Latin America NGS-based RNA-sequencing Revenue by Type (2018-2034)
9.3 Latin America NGS-based RNA-sequencing Revenue by Application (2018-2034)
9.4 Latin America NGS-based RNA-sequencing Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa NGS-based RNA-sequencing Revenue by Company (2021-2024)
10.2 Middle East and Africa NGS-based RNA-sequencing Revenue by Type (2018-2034)
10.3 Middle East and Africa NGS-based RNA-sequencing Revenue by Application (2018-2034)
10.4 Middle East and Africa NGS-based RNA-sequencing Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-sequencing Products and Services
11.1.4 Illumina NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.1.5 Illumina NGS-based RNA-sequencing SWOT Analysis
11.1.6 Illumina Recent Development
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Details
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Products and Services
11.2.4 Thermo Fischer Scientific NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.2.5 Thermo Fischer Scientific NGS-based RNA-sequencing SWOT Analysis
11.2.6 Thermo Fischer Scientific Recent Development
11.3 Oxford Nanopore
11.3.1 Oxford Nanopore Company Details
11.3.2 Oxford Nanopore Business Overview
11.3.3 Oxford Nanopore NGS-based RNA-sequencing Products and Services
11.3.4 Oxford Nanopore NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.3.5 Oxford Nanopore NGS-based RNA-sequencing SWOT Analysis
11.3.6 Oxford Nanopore Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies NGS-based RNA-sequencing Products and Services
11.4.4 Agilent Technologies NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.4.5 Agilent Technologies NGS-based RNA-sequencing SWOT Analysis
11.4.6 Agilent Technologies Recent Development
11.5 BGI
11.5.1 BGI Company Details
11.5.2 BGI Business Overview
11.5.3 BGI NGS-based RNA-sequencing Products and Services
11.5.4 BGI NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.5.5 BGI NGS-based RNA-sequencing SWOT Analysis
11.5.6 BGI Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer NGS-based RNA-sequencing Products and Services
11.6.4 PerkinElmer NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.6.5 PerkinElmer NGS-based RNA-sequencing SWOT Analysis
11.6.6 PerkinElmer Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN NGS-based RNA-sequencing Products and Services
11.7.4 QIAGEN NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.7.5 QIAGEN NGS-based RNA-sequencing SWOT Analysis
11.7.6 QIAGEN Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific NGS-based RNA-sequencing Products and Services
11.8.4 Eurofins Scientific NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.8.5 Eurofins Scientific NGS-based RNA-sequencing SWOT Analysis
11.8.6 Eurofins Scientific Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche NGS-based RNA-sequencing Products and Services
11.9.4 Roche NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.9.5 Roche NGS-based RNA-sequencing SWOT Analysis
11.9.6 Roche Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio NGS-based RNA-sequencing Products and Services
11.10.4 Takara Bio NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.10.5 Takara Bio NGS-based RNA-sequencing SWOT Analysis
11.10.6 Takara Bio Recent Development
11.11 GENEWIZ
11.11.1 GENEWIZ Company Details
11.11.2 GENEWIZ Business Overview
11.11.3 GENEWIZ NGS-based RNA-sequencing Products and Services
11.11.4 GENEWIZ NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.11.5 GENEWIZ Recent Development
11.12 Hamilton
11.12.1 Hamilton Company Details
11.12.2 Hamilton Business Overview
11.12.3 Hamilton NGS-based RNA-sequencing Products and Services
11.12.4 Hamilton NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.12.5 Hamilton Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Details
11.13.2 Macrogen Business Overview
11.13.3 Macrogen NGS-based RNA-sequencing Products and Services
11.13.4 Macrogen NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.13.5 Macrogen Recent Development
11.14 Zymo Research
11.14.1 Zymo Research Company Details
11.14.2 Zymo Research Business Overview
11.14.3 Zymo Research NGS-based RNA-sequencing Products and Services
11.14.4 Zymo Research NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.14.5 Zymo Research Recent Development
11.15 Tecan Genomics
11.15.1 Tecan Genomics Company Details
11.15.2 Tecan Genomics Business Overview
11.15.3 Tecan Genomics NGS-based RNA-sequencing Products and Services
11.15.4 Tecan Genomics NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024)
11.15.5 Tecan Genomics Recent Development
12 NGS-based RNA-sequencing Market Dynamics
12.1 NGS-based RNA-sequencing Industry Trends
12.2 NGS-based RNA-sequencing Market Drivers
12.3 NGS-based RNA-sequencing Market Challenges
12.4 NGS-based RNA-sequencing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global NGS-based RNA-sequencing Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Sequencing by Synthesis
Table 3. Key Players of Ion Semiconductor Sequencing
Table 4. Key Players of Single-molecule Real-time Sequencing
Table 5. Key Players of Nanopore Sequencing
Table 6. Global NGS-based RNA-sequencing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 7. Global NGS-based RNA-sequencing Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 8. Global NGS-based RNA-sequencing Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global NGS-based RNA-sequencing Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 10. Global NGS-based RNA-sequencing Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 11. Global NGS-based RNA-sequencing Revenue by Players (2018-2024) & (US$ Million)
Table 12. Global NGS-based RNA-sequencing Market Share by Players (2018-2024)
Table 13. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2022)
Table 14. Ranking of Global Top NGS-based RNA-sequencing Companies by Revenue (US$ Million) in 2022
Table 15. Global 5 Largest Players Market Share by NGS-based RNA-sequencing Revenue (CR5 and HHI) & (2018-2024)
Table 16. Global Key Players of NGS-based RNA-sequencing, Headquarters and Area Served
Table 17. Global Key Players of NGS-based RNA-sequencing, Product and Application
Table 18. Global Key Players of NGS-based RNA-sequencing, Date of Enter into This Industry
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global NGS-based RNA-sequencing Market Size by Type (2018-2024) & (US$ Million)
Table 21. Global NGS-based RNA-sequencing Revenue Market Share by Type (2018-2024)
Table 22. Global NGS-based RNA-sequencing Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 23. Global NGS-based RNA-sequencing Revenue Market Share by Type (2024-2034)
Table 24. Global NGS-based RNA-sequencing Market Size by Application (2018-2024) & (US$ Million)
Table 25. Global NGS-based RNA-sequencing Revenue Market Share by Application (2018-2024)
Table 26. Global NGS-based RNA-sequencing Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 27. Global NGS-based RNA-sequencing Revenue Market Share by Application (2024-2034)
Table 28. North America NGS-based RNA-sequencing Revenue by Company (2021-2024) & (US$ Million)
Table 29. North America NGS-based RNA-sequencing Revenue by Type (2018-2024) & (US$ Million)
Table 30. North America NGS-based RNA-sequencing Revenue by Type (2024-2034) & (US$ Million)
Table 31. North America NGS-based RNA-sequencing Revenue by Application (2018-2024) & (US$ Million)
Table 32. North America NGS-based RNA-sequencing Revenue by Application (2024-2034) & (US$ Million)
Table 33. North America NGS-based RNA-sequencing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 34. North America NGS-based RNA-sequencing Revenue by Country (2018-2024) & (US$ Million)
Table 35. North America NGS-based RNA-sequencing Revenue by Country (2024-2034) & (US$ Million)
Table 36. Europe NGS-based RNA-sequencing Revenue by Company (2021-2024) & (US$ Million)
Table 37. Europe NGS-based RNA-sequencing Revenue by Type (2018-2024) & (US$ Million)
Table 38. Europe NGS-based RNA-sequencing Revenue by Type (2024-2034) & (US$ Million)
Table 39. Europe NGS-based RNA-sequencing Revenue by Application (2018-2024) & (US$ Million)
Table 40. Europe NGS-based RNA-sequencing Revenue by Application (2024-2034) & (US$ Million)
Table 41. Europe NGS-based RNA-sequencing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 42. Europe NGS-based RNA-sequencing Revenue by Country (2018-2024) & (US$ Million)
Table 43. Europe NGS-based RNA-sequencing Revenue by Country (2024-2034) & (US$ Million)
Table 44. Asia Pacific NGS-based RNA-sequencing Revenue by Company (2021-2024) & (US$ Million)
Table 45. Asia Pacific NGS-based RNA-sequencing Revenue by Type (2018-2024) & (US$ Million)
Table 46. Asia Pacific NGS-based RNA-sequencing Revenue by Type (2024-2034) & (US$ Million)
Table 47. Asia Pacific NGS-based RNA-sequencing Revenue by Application (2018-2024) & (US$ Million)
Table 48. Asia Pacific NGS-based RNA-sequencing Revenue by Application (2024-2034) & (US$ Million)
Table 49. Asia-Pacific NGS-based RNA-sequencing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 50. Asia Pacific NGS-based RNA-sequencing Revenue by Region (2018-2024) & (US$ Million)
Table 51. Asia Pacific NGS-based RNA-sequencing Revenue by Region (2024-2034) & (US$ Million)
Table 52. Latin America NGS-based RNA-sequencing Revenue by Company (2021-2024) & (US$ Million)
Table 53. Latin America NGS-based RNA-sequencing Revenue by Type (2018-2024) & (US$ Million)
Table 54. Latin America NGS-based RNA-sequencing Revenue by Type (2024-2034) & (US$ Million)
Table 55. Latin America NGS-based RNA-sequencing Revenue by Application (2018-2024) & (US$ Million)
Table 56. Latin America NGS-based RNA-sequencing Revenue by Application (2024-2034) & (US$ Million)
Table 57. Latin America NGS-based RNA-sequencing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 58. Latin America NGS-based RNA-sequencing Revenue by Country (2018-2024) & (US$ Million)
Table 59. Latin America NGS-based RNA-sequencing Revenue by Country (2024-2034) & (US$ Million)
Table 60. Middle East and Africa NGS-based RNA-sequencing Revenue by Company (2021-2024) & (US$ Million)
Table 61. Middle East and Africa NGS-based RNA-sequencing Revenue by Type (2018-2024) & (US$ Million)
Table 62. Middle East and Africa NGS-based RNA-sequencing Revenue by Type (2024-2034) & (US$ Million)
Table 63. Middle East and Africa NGS-based RNA-sequencing Revenue by Application (2018-2024) & (US$ Million)
Table 64. Middle East and Africa NGS-based RNA-sequencing Revenue by Application (2024-2034) & (US$ Million)
Table 65. Middle East and Africa NGS-based RNA-sequencing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 66. Middle East and Africa NGS-based RNA-sequencing Revenue by Country (2018-2024) & (US$ Million)
Table 67. Middle East and Africa NGS-based RNA-sequencing Revenue by Country (2024-2034) & (US$ Million)
Table 68. Illumina Company Details
Table 69. Illumina Business Overview
Table 70. Illumina NGS-based RNA-sequencing Product and Services
Table 71. Illumina NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 72. Illumina NGS-based RNA-sequencing SWOT Analysis
Table 73. Illumina Recent Development
Table 74. Thermo Fischer Scientific Company Details
Table 75. Thermo Fischer Scientific Business Overview
Table 76. Thermo Fischer Scientific NGS-based RNA-sequencing Product and Services
Table 77. Thermo Fischer Scientific NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 78. Thermo Fischer Scientific NGS-based RNA-sequencing SWOT Analysis
Table 79. Thermo Fischer Scientific Recent Development
Table 80. Oxford Nanopore Company Details
Table 81. Oxford Nanopore Business Overview
Table 82. Oxford Nanopore NGS-based RNA-sequencing Product and Services
Table 83. Oxford Nanopore NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 84. Oxford Nanopore NGS-based RNA-sequencing SWOT Analysis
Table 85. Oxford Nanopore Recent Development
Table 86. Agilent Technologies Company Details
Table 87. Agilent Technologies Business Overview
Table 88. Agilent Technologies NGS-based RNA-sequencing Product and Services
Table 89. Agilent Technologies NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 90. Agilent Technologies NGS-based RNA-sequencing SWOT Analysis
Table 91. Agilent Technologies Recent Development
Table 92. BGI Company Details
Table 93. BGI Business Overview
Table 94. BGI NGS-based RNA-sequencing Product and Services
Table 95. BGI NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 96. BGI NGS-based RNA-sequencing SWOT Analysis
Table 97. BGI Recent Development
Table 98. PerkinElmer Company Details
Table 99. PerkinElmer Business Overview
Table 100. PerkinElmer NGS-based RNA-sequencing Product and Services
Table 101. PerkinElmer NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 102. PerkinElmer NGS-based RNA-sequencing SWOT Analysis
Table 103. PerkinElmer Recent Development
Table 104. QIAGEN Company Details
Table 105. QIAGEN Business Overview
Table 106. QIAGEN NGS-based RNA-sequencing Product and Services
Table 107. QIAGEN NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 108. QIAGEN NGS-based RNA-sequencing SWOT Analysis
Table 109. QIAGEN Recent Development
Table 110. Eurofins Scientific Company Details
Table 111. Eurofins Scientific Business Overview
Table 112. Eurofins Scientific NGS-based RNA-sequencing Product and Services
Table 113. Eurofins Scientific NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 114. Eurofins Scientific NGS-based RNA-sequencing SWOT Analysis
Table 115. Eurofins Scientific Recent Development
Table 116. Roche Company Details
Table 117. Roche Business Overview
Table 118. Roche NGS-based RNA-sequencing Product and Services
Table 119. Roche NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 120. Roche NGS-based RNA-sequencing SWOT Analysis
Table 121. Roche Recent Development
Table 122. Takara Bio Company Details
Table 123. Takara Bio Business Overview
Table 124. Takara Bio NGS-based RNA-sequencing Product and Services
Table 125. Takara Bio NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 126. Takara Bio NGS-based RNA-sequencing SWOT Analysis
Table 127. Takara Bio Recent Development
Table 128. GENEWIZ Company Details
Table 129. GENEWIZ Business Overview
Table 130. GENEWIZ NGS-based RNA-sequencing Product and Services
Table 131. GENEWIZ NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 132. GENEWIZ Recent Development
Table 133. Hamilton Company Details
Table 134. Hamilton Business Overview
Table 135. Hamilton NGS-based RNA-sequencing Product and Services
Table 136. Hamilton NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 137. Hamilton Recent Development
Table 138. Macrogen Company Details
Table 139. Macrogen Business Overview
Table 140. Macrogen NGS-based RNA-sequencing Product and Services
Table 141. Macrogen NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 142. Macrogen Recent Development
Table 143. Zymo Research Company Details
Table 144. Zymo Research Business Overview
Table 145. Zymo Research NGS-based RNA-sequencing Product and Services
Table 146. Zymo Research NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 147. Zymo Research Recent Development
Table 148. Tecan Genomics Company Details
Table 149. Tecan Genomics Business Overview
Table 150. Tecan Genomics NGS-based RNA-sequencing Product and Services
Table 151. Tecan Genomics NGS-based RNA-sequencing Revenue in NGS-based RNA-sequencing Business (2018-2024) & (US$ Million)
Table 152. Tecan Genomics Recent Development
Table 153. NGS-based RNA-sequencing Market Trends
Table 154. NGS-based RNA-sequencing Market Drivers
Table 155. NGS-based RNA-sequencing Market Challenges
Table 156. NGS-based RNA-sequencing Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. NGS-based RNA-sequencing Product Picture
Figure 2. Global NGS-based RNA-sequencing Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global NGS-based RNA-sequencing Market Share by Type: 2022 VS 2034
Figure 4. Sequencing by Synthesis Features
Figure 5. Ion Semiconductor Sequencing Features
Figure 6. Single-molecule Real-time Sequencing Features
Figure 7. Nanopore Sequencing Features
Figure 8. Global NGS-based RNA-sequencing Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 9. Global NGS-based RNA-sequencing Market Share by Application: 2022 VS 2034
Figure 10. Research & Academia
Figure 11. Hospitals & Clinics
Figure 12. Pharmaceutical & Biotechnology Companies
Figure 13. Others
Figure 14. NGS-based RNA-sequencing Report Years Considered
Figure 15. Global NGS-based RNA-sequencing Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global NGS-based RNA-sequencing Market Size 2018-2034 (US$ Million)
Figure 17. Global NGS-based RNA-sequencing Market Size Market Share by Region: 2022 VS 2034
Figure 18. Global NGS-based RNA-sequencing Revenue Market Share by Region in 2018 VS 2022
Figure 19. Global NGS-based RNA-sequencing Revenue Market Share Forecast by Region (2024-2034)
Figure 20. Global Top 10 NGS-based RNA-sequencing Countries Ranking by Market Size (US$ Million) in 2022
Figure 21. Global NGS-based RNA-sequencing Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 22. Global NGS-based RNA-sequencing Market Share by Players in 2022
Figure 23. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2022)
Figure 24. The Top 10 and 5 Players Market Share by NGS-based RNA-sequencing Revenue in 2022
Figure 25. North America NGS-based RNA-sequencing Revenue Market Share by Company in 2022
Figure 26. North America NGS-based RNA-sequencing Revenue Market Share by Type (2018-2034)
Figure 27. North America NGS-based RNA-sequencing Revenue Market Share by Application (2018-2034)
Figure 28. North America NGS-based RNA-sequencing Revenue Share by Country (2018-2034)
Figure 29. U.S. NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 30. Canada NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 31. Europe NGS-based RNA-sequencing Revenue Market Share by Company in 2022
Figure 32. Europe NGS-based RNA-sequencing Revenue Market Share by Type (2018-2034)
Figure 33. Europe NGS-based RNA-sequencing Revenue Market Share by Application (2018-2034)
Figure 34. Europe NGS-based RNA-sequencing Revenue Share by Country (2018-2034)
Figure 35. Germany NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 36. France NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 37. U.K. NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 38. Italy NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 39. Russia NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 40. Asia Pacific NGS-based RNA-sequencing Revenue Market Share by Company in 2022
Figure 41. Asia Pacific NGS-based RNA-sequencing Revenue Market Share by Type (2018-2034)
Figure 42. Asia Pacific NGS-based RNA-sequencing Revenue Market Share by Application (2018-2034)
Figure 43. Asia Pacific NGS-based RNA-sequencing Revenue Share by Region (2018-2034)
Figure 44. China NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 45. Japan NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 46. South Korea NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 47. India NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 48. Australia NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 49. Taiwan NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 50. Indonesia NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 51. Thailand NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 52. Malaysia NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 53. Philippines NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 54. Vietnam NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 55. Latin America NGS-based RNA-sequencing Revenue Market Share by Company in 2022
Figure 56. Latin America NGS-based RNA-sequencing Revenue Market Share by Type (2018-2034)
Figure 57. Latin America NGS-based RNA-sequencing Revenue Market Share by Application (2018-2034)
Figure 58. Latin America NGS-based RNA-sequencing Revenue Share by Country (2018-2034)
Figure 59. Mexico NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 60. Brazil NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 61. Argentina NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 62. Middle East and Africa NGS-based RNA-sequencing Revenue Market Share by Company in 2022
Figure 63. Middle East and Africa NGS-based RNA-sequencing Revenue Market Share by Type (2018-2034)
Figure 64. Middle East and Africa NGS-based RNA-sequencing Revenue Market Share by Application (2018-2034)
Figure 65. Middle East and Africa NGS-based RNA-sequencing Revenue Share by Country (2018-2034)
Figure 66. Turkey NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 67. Saudi Arabia NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 68. U.A.E NGS-based RNA-sequencing Revenue (2018-2034) & (US$ Million)
Figure 69. Illumina Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 70. Thermo Fischer Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 71. Oxford Nanopore Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 72. Agilent Technologies Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 73. BGI Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 74. PerkinElmer Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 75. QIAGEN Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 76. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 77. Roche Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 78. Takara Bio Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 79. GENEWIZ Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 80. Hamilton Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 81. Macrogen Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 82. Zymo Research Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 83. Tecan Genomics Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2024)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries